Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
7.00
-2.54 (-26.62%)
At close: Jun 26, 2026, 4:00 PM EDT
7.49
+0.49 (7.00%)
After-hours: Jun 26, 2026, 7:28 PM EDT
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $29.31 million as of June 26, 2026. Its market cap has decreased by -88.10% in one year.
Market Cap
29.31M
Enterprise Value
38.09M
1-Year Change
-88.10%
Ranking
Category
Stock Price
$7.00
Market Cap Chart
Since January 5, 2022, Tevogen Bio Holdings's market cap has decreased from $446.69M to $29.31M, a decrease of -93.44%. That is a compound annual growth rate of -45.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 29.31M | -55.44% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 46.59M |
| CervoMed | 45.31M |
| Hyperion DeFi | 44.87M |
| Metagenomi Therapeutics | 44.80M |
| RenovoRx | 41.94M |
| Estrella Immunopharma | 41.31M |
| Genenta Science | 40.81M |
| INmune Bio | 39.61M |